Rani Therapeutics Holdings, Inc. SEC filings RANI

Rani Therapeutics Holdings, Inc. has 380 filings in SEC EDGAR's recent list, going back to Apr 27, 2021. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.

Rani Therapeutics Holdings, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Sep 29, 2026 Sep 27, 2026
4 Insider transaction Sep 29, 2026 Sep 27, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
4 Insider transaction Aug 4, 2026 Aug 3, 2026
3 Initial insider ownership Aug 4, 2026 Aug 1, 2026
8-K Current report
Officer or director change
Aug 4, 2026 Aug 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 31, 2026 —
4 Insider transaction Jul 23, 2026 Jul 21, 2026
4 Insider transaction Jul 21, 2026 Mar 27, 2026
4 Insider transaction Jul 21, 2026 Jul 17, 2026
4 Insider transaction Jul 21, 2026 Dec 27, 2024
4 Insider transaction Jul 21, 2026 Jul 17, 2026
S-8 Employee stock plan registration Jul 15, 2026 —
3 Initial insider ownership Jul 8, 2026 Jun 29, 2026
8-K Current report
Officer or director change
Jun 30, 2026 Jun 24, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
8-K Current report
Shareholder vote results
May 29, 2026 May 28, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) May 28, 2026 —
8-K Current report
Other events
May 27, 2026 May 26, 2026
424B5 Prospectus supplement May 27, 2026 —
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Results of operations, Listing notice, Officer or director change
May 15, 2026 May 11, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
ARS Annual report to shareholders Apr 16, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 16, 2026 —
DEF 14A Proxy statement Apr 16, 2026 May 28, 2026
3 Initial insider ownership Mar 27, 2026 Mar 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
S-8 Employee stock plan registration Mar 26, 2026 —
10-K Annual report Mar 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 26, 2026 Mar 26, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 12, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jan 30, 2026 —
8-K Current report
Agreement ended, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
Jan 2, 2026 Dec 31, 2025
DEF 14C Information statement Dec 5, 2025 Dec 5, 2025
EFFECT Filing Dec 3, 2025 —
424B5 Prospectus supplement Dec 3, 2025 —
CORRESP Letter to the SEC Dec 1, 2025 —
PRE 14C Filing Nov 25, 2025 Nov 25, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
D Filing Nov 10, 2025 —
S-3 Shelf registration Nov 7, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
SCHEDULE 13D Ownership over 5% (active) Oct 30, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Oct 30, 2025 —
4 Insider transaction Oct 30, 2025 Oct 23, 2025
3 Initial insider ownership Oct 30, 2025 Oct 23, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 27, 2025 —
4 Insider transaction Oct 27, 2025 Oct 23, 2025
3 Initial insider ownership Oct 27, 2025 Oct 23, 2025
4 Insider transaction Oct 27, 2025 Oct 23, 2025
8-K Current report
Officer or director change, Other events
Oct 27, 2025 Oct 22, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 23, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 22, 2025 —
4 Insider transaction Oct 22, 2025 Oct 20, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Oct 17, 2025 Oct 16, 2025
EFFECT Filing Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
CORRESP Letter to the SEC Aug 12, 2025 —
UPLOAD Letter from the SEC Aug 12, 2025 —
S-3 Shelf registration Aug 8, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 23, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jul 17, 2025 —
8-K Current report
Other events
Jul 16, 2025 Jul 14, 2025
424B5 Prospectus supplement Jul 16, 2025 —
EFFECT Filing Jul 11, 2025 —
424B5 Prospectus supplement Jul 11, 2025 —
DEF 14C Information statement Jul 10, 2025 Jul 10, 2025
CORRESP Letter to the SEC Jul 9, 2025 —
UPLOAD Letter from the SEC Jul 8, 2025 —
S-3 Shelf registration Jul 3, 2025 —
PRE 14C Filing Jun 30, 2025 Jun 30, 2025
8-K Current report
Listing notice
Jun 26, 2025 Jun 20, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
8-K Current report
Shareholder vote results
May 29, 2025 May 28, 2025
4 Insider transaction May 23, 2025 May 23, 2025
4 Insider transaction May 23, 2025 May 23, 2025
4 Insider transaction May 23, 2025 May 23, 2025
4 Insider transaction May 23, 2025 May 23, 2025
8-K Current report
Material agreement, Unregistered share sale
May 20, 2025 May 20, 2025
424B5 Prospectus supplement May 19, 2025 —
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
8-K Current report
Listing notice
May 6, 2025 May 1, 2025
DEFA14A Additional proxy material Apr 30, 2025 —
8-K Current report
Officer or director change
Apr 30, 2025 Apr 24, 2025
ARS Annual report to shareholders Apr 16, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 16, 2025 —
DEF 14A Proxy statement Apr 16, 2025 May 28, 2025
8-K Current report
Auditor change
Apr 9, 2025 Apr 7, 2025
S-8 Employee stock plan registration Mar 31, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
4 Insider transaction Dec 17, 2024 Dec 16, 2024
4 Insider transaction Dec 17, 2024 Dec 16, 2024
4 Insider transaction Dec 17, 2024 Dec 16, 2024
4 Insider transaction Dec 17, 2024 Dec 16, 2024
4 Insider transaction Dec 17, 2024 Dec 16, 2024
4 Insider transaction Dec 17, 2024 Dec 16, 2024
4 Insider transaction Dec 17, 2024 Dec 16, 2024
4 Insider transaction Dec 16, 2024 Dec 13, 2024
4 Insider transaction Dec 10, 2024 Dec 9, 2024
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
SC 13D/A Amended ownership over 5% (active) Oct 17, 2024 —
4 Insider transaction Oct 17, 2024 Oct 15, 2024
8-K Current report
Other events
Oct 16, 2024 Oct 15, 2024
424B5 Prospectus supplement Oct 16, 2024 —
8-K Current report
Auditor change
Sep 11, 2024 Sep 10, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report Aug 6, 2024 Aug 6, 2024
8-K Current report
Other events
Jul 23, 2024 Jul 22, 2024
424B5 Prospectus supplement Jul 23, 2024 —
8-K Current report
Regulation FD disclosure
Jul 12, 2024 Jul 12, 2024
8-K Current report
Material agreement, Other events
Jun 24, 2024 Jun 17, 2024
4 Insider transaction May 30, 2024 May 29, 2024
4 Insider transaction May 30, 2024 May 29, 2024
4 Insider transaction May 30, 2024 May 29, 2024
4 Insider transaction May 30, 2024 May 29, 2024
4 Insider transaction May 30, 2024 May 29, 2024
4 Insider transaction May 30, 2024 May 29, 2024
4 Insider transaction May 30, 2024 May 29, 2024
8-K Current report
Shareholder vote results
May 30, 2024 May 29, 2024
10-Q Quarterly report May 6, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 6, 2024 May 6, 2024
ARS Annual report to shareholders Apr 17, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 17, 2024 —
DEF 14A Proxy statement Apr 17, 2024 May 29, 2024
4 Insider transaction Mar 22, 2024 Mar 21, 2024
4 Insider transaction Mar 22, 2024 Mar 21, 2024
4 Insider transaction Mar 22, 2024 Mar 21, 2024
4 Insider transaction Mar 22, 2024 Mar 21, 2024
4 Insider transaction Mar 22, 2024 Mar 21, 2024
S-8 Employee stock plan registration Mar 20, 2024 —
10-K Annual report Mar 20, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 20, 2024 Mar 20, 2024
8-K Current report
Regulation FD disclosure, Other events
Feb 5, 2024 Feb 5, 2024
8-K Current report
Officer or director change
Dec 19, 2023 Dec 16, 2023
4 Insider transaction Dec 19, 2023 Dec 16, 2023
4 Insider transaction Dec 19, 2023 Dec 16, 2023
4 Insider transaction Dec 19, 2023 Dec 16, 2023
4 Insider transaction Dec 19, 2023 Dec 16, 2023
4 Insider transaction Dec 19, 2023 Dec 16, 2023
4 Insider transaction Dec 19, 2023 Dec 16, 2023
4 Insider transaction Dec 19, 2023 Dec 16, 2023
4 Insider transaction Dec 19, 2023 Dec 16, 2023
4 Insider transaction Dec 19, 2023 Dec 16, 2023
4 Insider transaction Dec 19, 2023 Dec 16, 2023
4 Insider transaction Dec 19, 2023 Dec 16, 2023
4 Insider transaction Dec 19, 2023 Dec 16, 2023
8-K Current report
Other events
Dec 14, 2023 Dec 14, 2023
SC 13D/A Amended ownership over 5% (active) Dec 8, 2023 —
SC 13D/A Amended ownership over 5% (active) Dec 8, 2023 —
4 Insider transaction Dec 8, 2023 Nov 24, 2023
4 Insider transaction Dec 8, 2023 Nov 24, 2023
4 Insider transaction Dec 7, 2023 Dec 6, 2023
4 Insider transaction Dec 6, 2023 Dec 4, 2023
4 Insider transaction Dec 1, 2023 Nov 29, 2023
4 Insider transaction Nov 21, 2023 Nov 17, 2023
4 Insider transaction Nov 20, 2023 Nov 16, 2023
4 Insider transaction Nov 9, 2023 Nov 7, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations, Officer or director change
Nov 8, 2023 Nov 8, 2023
8-K Current report
Material agreement, Results of operations, Exit or restructuring costs
Nov 1, 2023 Nov 1, 2023
8-K Current report
Other events
Oct 25, 2023 Oct 25, 2023
8-K Current report
Other events
Sep 7, 2023 Sep 7, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 11, 2023 Aug 11, 2023
4 Insider transaction Aug 8, 2023 Aug 7, 2023
3 Initial insider ownership Aug 8, 2023 Aug 7, 2023
8-K Current report
Material agreement
Jun 5, 2023 Jun 1, 2023
4 Insider transaction May 30, 2023 May 25, 2023
4 Insider transaction May 30, 2023 May 25, 2023
4 Insider transaction May 30, 2023 May 25, 2023
4 Insider transaction May 30, 2023 May 25, 2023
4 Insider transaction May 30, 2023 May 25, 2023
4 Insider transaction May 30, 2023 May 25, 2023
4 Insider transaction May 30, 2023 May 25, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RANI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
CA
Headquarters
San Jose, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1856725

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.